miR-29a-3p shows distinct low expression in STB patients' peripheral blood, associated with inflammation activity and conventional diagnostic indicators, making it a promising auxiliary biomarker. Critically, integrating miR-29a-3p into combined detection strategies enhances and optimizes current STB diagnostic frameworks, addressing unmet clinical needs for more accurate and efficient diagnosis, thus holding substantial value for improving STB management.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: